BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Dai L, Goldstein A, Zhang H, Tang W, Forrest JC, Post SR, Chen X, Qin Z. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation. PLoS Pathog 2019;15:e1008156. [PMID: 31790497 DOI: 10.1371/journal.ppat.1008156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Zhang H, Chen X. Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis. Antiviral Res 2020;180:104825. [PMID: 32461120 DOI: 10.1016/j.antiviral.2020.104825] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Venkateswaran N, Ramos JC, Cohen AK, Alvarez OP, Cohen NK, Galor A, Karp CL. Spotlight on ocular Kaposi’s sarcoma: an update on the presentation, diagnosis, and management options. Expert Review of Ophthalmology 2021;16:477-89. [DOI: 10.1080/17469899.2021.1962294] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Broussard G, Damania B. Regulation of KSHV Latency and Lytic Reactivation. Viruses 2020;12:E1034. [PMID: 32957532 DOI: 10.3390/v12091034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
4 Dubich T, Dittrich A, Bousset K, Geffers R, Büsche G, Köster M, Hauser H, Schulz TF, Wirth D. 3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells. J Mol Med (Berl) 2021;99:425-38. [PMID: 33484281 DOI: 10.1007/s00109-020-02020-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ming J, Liu W, Wu H, Li Y, Yang E, Wang Z, Xiao H, Quan R, Hu X. The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation. Biomed Pharmacother 2021;140:111767. [PMID: 34058439 DOI: 10.1016/j.biopha.2021.111767] [Reference Citation Analysis]
6 Ngalamika O, Munsaka S. Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma. J Immunol Res 2020;2020:8852221. [PMID: 33294468 DOI: 10.1155/2020/8852221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Dai L, Jung BG, Chen J, Samten B, Forrest JC, Post SR, Qin Z. The potential impacts of early secreted antigenic target of 6 kDa of Mycobacterium tuberculosis on KSHV-infected cells. J Med Virol 2021;93:4028-32. [PMID: 32648938 DOI: 10.1002/jmv.26291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kumari S, Sharma S, Advani D, Khosla A, Kumar P, Ambasta RK. Unboxing the molecular modalities of mutagens in cancer. Environ Sci Pollut Res Int 2021. [PMID: 34611806 DOI: 10.1007/s11356-021-16726-w] [Reference Citation Analysis]
9 Iftode N, Rădulescu MA, Aramă ȘS, Aramă V. Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) - review. Rom J Intern Med 2020;58:199-208. [PMID: 32681788 DOI: 10.2478/rjim-2020-0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sandhu PK, Damania B. The regulation of KSHV lytic reactivation by viral and cellular factors. Curr Opin Virol 2021;52:39-47. [PMID: 34872030 DOI: 10.1016/j.coviro.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Long W, Zhao G, Wu Y. Endoplasmic Reticulum-Shaping Atlastin Proteins Facilitate KSHV Replication. Front Cell Infect Microbiol 2022;11:790243. [DOI: 10.3389/fcimb.2021.790243] [Reference Citation Analysis]
12 Shangguan A, Li J, Sun Y, Liu Z, Zhang S. Host-virus interactions in PK-15 cells infected with Pseudorabies virus Becker strain based on RNA-seq. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198829] [Reference Citation Analysis]
13 Yang L, Pei RJ, Li H, Ma XN, Zhou Y, Zhu FH, He PL, Tang W, Zhang YC, Xiong J, Xiao SQ, Tong XK, Zhang B, Zuo JP. Identification of SARS-CoV-2 entry inhibitors among already approved drugs. Acta Pharmacol Sin 2021;42:1347-53. [PMID: 33116249 DOI: 10.1038/s41401-020-00556-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]